RDP58, a novel immunomodulatory peptide, ameliorates clinical signs of disease in the Lewis rat model of acute experimental autoimmune encephalomyelitis

Journal of Neuroimmunology

Volumn 152, Issue 1-2, 2004, Pages 33-43

  DeVry, Christopher G ^a   Valdez, Marybeth ^a   Gao, Lan ^a   Wang, Jing ^a   Kotsch, Katja ^b   Volk, Hans Dieter ^b   Bechmann, Ingo ^b   Buelow, Roland ^a   Iyer, Suhasini ^a  

^a GENZYME CORPORATION   (United States)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Autoimmune; Experimental autoimmune encephalomyelitis (EAE); Inflammation; Multiple sclerosis; RDP58; Tumor necrosis factor alpha (TNF )

Indexed keywords

CYTOKINE; DEXTRO ARGINYL DEXTRO NORLEUCYL DEXTRO NORLEUCYL DEXTRO NORLEUCYL DEXTRO ARGINYL DEXTRO NORLEUCYL DEXTRO NORLEUCYL DEXTRO NORLEUCYLGLYCYL DEXTRO TYROSINAMIDE; GAMMA INTERFERON; HEME OXYGENASE 1; IMMUNOMODULATING AGENT; INTERLEUKIN 12; PEPTIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CELL INFILTRATION; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; INFLAMMATORY DISEASE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPINAL CORD;

ANIMALS; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; INJECTIONS, INTRAVENTRICULAR; PEPTIDES; RATS; RATS, INBRED LEW; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPINAL CORD; TUMOR NECROSIS FACTOR-ALPHA;

EID: 3042610075     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2004.03.020     Document Type: Article

References (39)

1. Achiron A., Miron S., Lavie V., Margalit R., Biegon A. Dexanabinol (HU-211) effect on experimental autoimmune encephalomyelitis: implications for the treatment of acute relapses of multiple sclerosis. J. Neuroimmunol. 102:2000;26-31
2. Bettelli E., Das M.P., Howard E.D., Weiner H.L., Sobel R.A., Kuchroo V.K. IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice. J. Immunol. 161:1998;3299-3306
3. Boismenu R., Chen Y., Chou K., El-Sheikh A., Buelow R. Orally administered RDP58 reduces the severity of dextran sodium sulphate induced colitis. Ann. Rheum. Dis. 61(Suppl. 2):2002;ii19-ii24
4. Buelow R., Veyron P., Clayberger C., Pouletty P., Touraine J.L. Prolongation of skin allograft survival in mice following administration of ALLOTRAP. Transplantation. 59:1995;455-460
5. Cross A.H., Manning P.T., Stern M.K., Misko T.P. Evidence for the production of peroxynitrite in inflammatory CNS demyelination. J. Neuroimmunol. 80:1997;121-130
6. Cross A.H., Manning P.T., Keeling R.M., Schmidt R.E., Misko T.P. Peroxynitrite formation within the central nervous system in active multiple sclerosis. J. Neuroimmunol. 88:1998;45-56
7. Cuturi M.C., Josein R., Douillard P., Pannetier C., Cantarovich D., Smit H., Menoret S., Pouletty P., Clayberger C., Soulillou J.P. Prolongation of allogeneic heart graft survival in rats by administration of a peptide (aa 75-84) from the alpha 1 helix of the first domain of HLA-B7 01. Transplantation. 59:1995;661-669
8. Cuturi M.C., Christoph F., Woo J., Iyer S., Brouard S., Heslan J.M., Pignon P., Soulillou J.P., Buelow R. RDP1258, a new rationally designed immunosuppressive peptide, prolongs allograft survival in rats: analysis of its mechanism of action. Mol. Med. 5:1999;820-832
9. Dore-Duffy P., Balabanov R., Rafols J., Swanborg R.H. Recovery phase of acute experimental autoimmune encephalomyelitis in rats corresponds to development of endothelial cell unresponsiveness to interferon gamma activation. J. Neurosci. Res. 44:1996;223-234
10. Emerson M.R., LeVine S.M. Heme oxygenase-1 and NADPH cytochrome P450 reductase expression in experimental allergic encephalomyelitis: an expanded view of the stress response. J. Neurochem. 75:2000;2555-2562
11. Gao L., Woo J., Buelow R. Both L- and D-isomers of Allotrap 2702 prolong cardiac allograft survival in mice. J. Heart Lung Transplant. 15:1996;78-87
12. Grassy G., Calas B., Yasri A., Lahana R., Woo J., Iyer S., Kaczorek M., Floc'h R., Buelow R. Computer-assisted rational design of immunosuppressive compounds. Nat. Biotechnol. 16:1998;748-752
13. Group M.A. The Lenercept Multiple Sclerosis Study Group and the University of British Columbia MS/MRI Analysis Group. TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study. Neurology. 53:1999;457-465
14. Hanaway M.J., Geissler E.K., Wang J., Fechner J.J., Buelow R., Knechtle S.J. Immunosuppressive effects of an HLA class-I derived peptide in a rat cardiac allograft model. Transplantation. 61:1996;1222-1228
15. Hemmer B., Archelos J.J., Hartung H.P. New concepts in the immunopathogenesis of multiple sclerosis. Nat. Rev., Neurosci. 3:2002;291-301
16. Hohlfeld R., Wiendl H. The ups and downs of multiple sclerosis therapeutics. Ann. Neurol. 49:2001;281-284
17. Iyer S., Woo J., Cornejo M.C., Gao L., McCoubrey W., Maines M., Buelow R. Characterization and biological significance of immunosuppressive peptide D2702.75-84(E→V) binding protein. Isolation of heme oxygenase-1. J. Biol. Chem. 273:1998;2692-2697
18. Iyer S., Lahana R., Buelow R. Rational design and development of RDP58. Curr. Pharm. Des. 8:2002;2217-2229
19. Juedes A.E., Ruddle N.H. Resident and infiltrating central nervous system APCs regulate the emergence and resolution of experimental autoimmune encephalomyelitis. J. Immunol. 166:2001;5168-5175
20. Kawashima A., Oda Y., Yachie A., Koizumi S., Nakanishi I. Heme oxygenase-1 deficiency: the first autopsy case. Hum. Pathol. 33:2002;125-130
21. Lazarov M., Welihinda A., Muhr E., Mo L., Buelow R., Fong T. RDP58, a novel anti-inflammatory peptide, inhibits multiple intracellular messenger pathways and transcription factor to block TNF-α, IFN-γ, and IL12 production. Digestive Disease Week 2003. Gastroenterology. 124(4 (Suppl. 1)):2003;A-102. Orlando, Florida, May 18-22
22. Liu Y., Zhu B., Luo L., Li P., Paty D.W., Cynader M.S. Heme oxygenase-1 plays an important protective role in experimental autoimmune encephalomyelitis. NeuroReport. 12:2001;1841-1845
23. Liu Y., Zhu B., Wang X., Luo L., Li P., Paty D.W., Cynader M.S. Bilirubin as a potent antioxidant suppresses experimental autoimmune encephalomyelitis: implications for the role of oxidative stress in the development of multiple sclerosis. J. Neuroimmunol. 139:2003;27-35
24. Martin R., Sturzebecher C.S., McFarland H.F. Immunotherapy of multiple sclerosis: where are we? Where should we go? Nat. Immunol. 2:2001;785-788
25. Murthy S., Flanigan A., Coppola D., Buelow R. RDP58, a locally active TNF inhibitor, is effective in the dextran sulphate mouse model of chronic colitis. Inflamm. Res. 51:2002;522-531
26. Oberyszyn T.M., Robertson F.M., Tober K.L., Ross M.S., Parrett M.L., Wilgus T.A., Iyer S., Woo J., Buelow R. Inhibition of cutaneous UV light-induced tumor necrosis factor-alpha protein production by Allotrap 1258, a novel immunomodulatory peptide. Photochem. Photobiol. 73:2001;184-190
27. Ohta K., Yachie A., Fujimoto K., Kaneda H., Wada T., Toma T., Seno A., Kasahara Y., Yokoyama H., Seki H., Koizumi S. Tubular injury as a cardinal pathologic feature in human heme oxygenase-1 deficiency. Am. J. Kidney Dis. 35:2000;863-870
28. Otterbein L.E., Choi A.M. Heme oxygenase: colors of defense against cellular stress. Am. J. Physiol., Lung Cell. Mol. Physiol. 279:2000;L1029-L1037
29. Poss K.D., Tonegawa S. Heme oxygenase-1 is required for mammalian iron reutilization. Proc. Natl. Acad. Sci. U. S. A. 94:1997;10919-10925
30. Rivers T., Schwentker F. Encephalomyelitis accompanied by myelin destruction experimentally produced in monkeys. J. Exp. Med. 61:1935;689-702
31. Rott O., Fleischer B., Cash E. Interleukin-10 prevents experimental allergic encephalomyelitis in rats. Eur. J. Immunol. 24:1994;1434-1440
32. Schluesener H.J., Seid K. Heme oxygenase-1 in lesions of rat experimental autoimmune encephalomyelitis and neuritis. J. Neuroimmunol. 110:2000;114-120
33. Steinman L. Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system. Cell. 85:1996;299-302
34. Steinman L. Immunotherapy of multiple sclerosis: the end of the beginning. Curr. Opin. Immunol. 13:2001;597-600
35. Stosic-Grujicic S., Savic-Radojevic A., Maksimovic-Ivanic D., Markovic M., Bumbasirevic V., Ramic Z., Mostarica-Stojkovic M. Down-regulation of experimental allergic encephalomyelitis in DA rats by tiazofurin. J. Neuroimmunol. 130:2002;66-77
36. Swanborg R.H. Experimental autoimmune encephalomyelitis in rodents as a model for human demyelinating disease. Clin. Immunol. Immunopathol. 77:1995;4-13
37. Willenborg D.O. Experimental allergic encephalomyelitis in the Lewis rat: studies on the mechanism of recovery from disease and acquired resistance to reinduction. J. Immunol. 123:1979;1145-1150
38. Willis D., Moore A.R., Frederick R., Willoughby D.A. Heme oxygenase: a novel target for the modulation of the inflammatory response. Nat. Med. 2:1996;87-90
39. Zamvil S.S., Steinman L. The T lymphocyte in experimental allergic encephalomyelitis. Annu. Rev. Immunol. 8:1990;579-621